Zakieh Vahedian, Ali Azimi, Seyed Mehdi Tabatabaei, Ghasem Fakhraie
{"title":"Quantifying latanoprost-induced conjunctival hyperemia by anterior segment optical coherence tomography angiography.","authors":"Zakieh Vahedian, Ali Azimi, Seyed Mehdi Tabatabaei, Ghasem Fakhraie","doi":"10.18240/ijo.2025.08.06","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To evaluate the mid-term effects of topical latanoprost 0.005% on vessel density (VD) of the bulbar conjunctiva using anterior segment optical coherence tomography angiography (OCTA).</p><p><strong>Methods: </strong>Thirty-four eyes of 21 patients and 18 eyes of 9 healthy subjects were recruited as the treatment and control groups, respectively. The treatment group was instructed to apply generic latanoprost 0.005% once daily at night, while the control group received no medication. Anterior segment OCTA was performed on all eyes at baseline, 3wk, and 12wk after initiation of latanoprost. The superficial bulbar conjunctival VD was measured in the superior, inferior, temporal, and nasal quadrants. A linear mixed model was used to compare the change in the VD between groups.</p><p><strong>Results: </strong>The change in the VD was not different between groups in temporal, and nasal quadrants at 3-week and 12-week time points. The VD in the superior bulbar conjunctiva was significantly increased after 12wk (<i>P</i>=0.029) while the change from baseline after 3wk was not different between groups (<i>P</i>=0.218). After adjustment for age and gender superior hemi (<i>P</i>=0.006) and center (<i>P</i>=0.016) of the inferior quadrant of bulbar conjunctiva showed increased VD after 12wk.</p><p><strong>Conclusion: </strong>The trend of changes in the superior and inferior conjunctival VD is increased following topical latanoprost administration and these changes can be quantified using anterior segment OCTA.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"18 8","pages":"1464-1469"},"PeriodicalIF":1.8000,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12311470/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18240/ijo.2025.08.06","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: To evaluate the mid-term effects of topical latanoprost 0.005% on vessel density (VD) of the bulbar conjunctiva using anterior segment optical coherence tomography angiography (OCTA).
Methods: Thirty-four eyes of 21 patients and 18 eyes of 9 healthy subjects were recruited as the treatment and control groups, respectively. The treatment group was instructed to apply generic latanoprost 0.005% once daily at night, while the control group received no medication. Anterior segment OCTA was performed on all eyes at baseline, 3wk, and 12wk after initiation of latanoprost. The superficial bulbar conjunctival VD was measured in the superior, inferior, temporal, and nasal quadrants. A linear mixed model was used to compare the change in the VD between groups.
Results: The change in the VD was not different between groups in temporal, and nasal quadrants at 3-week and 12-week time points. The VD in the superior bulbar conjunctiva was significantly increased after 12wk (P=0.029) while the change from baseline after 3wk was not different between groups (P=0.218). After adjustment for age and gender superior hemi (P=0.006) and center (P=0.016) of the inferior quadrant of bulbar conjunctiva showed increased VD after 12wk.
Conclusion: The trend of changes in the superior and inferior conjunctival VD is increased following topical latanoprost administration and these changes can be quantified using anterior segment OCTA.
期刊介绍:
· International Journal of Ophthalmology-IJO (English edition) is a global ophthalmological scientific publication
and a peer-reviewed open access periodical (ISSN 2222-3959 print, ISSN 2227-4898 online).
This journal is sponsored by Chinese Medical Association Xi’an Branch and obtains guidance and support from
WHO and ICO (International Council of Ophthalmology). It has been indexed in SCIE, PubMed,
PubMed-Central, Chemical Abstracts, Scopus, EMBASE , and DOAJ. IJO JCR IF in 2017 is 1.166.
IJO was established in 2008, with editorial office in Xi’an, China. It is a monthly publication. General Scientific
Advisors include Prof. Hugh Taylor (President of ICO); Prof.Bruce Spivey (Immediate Past President of ICO);
Prof.Mark Tso (Ex-Vice President of ICO) and Prof.Daiming Fan (Academician and Vice President,
Chinese Academy of Engineering.
International Scientific Advisors include Prof. Serge Resnikoff (WHO Senior Speciatist for Prevention of
blindness), Prof. Chi-Chao Chan (National Eye Institute, USA) and Prof. Richard L Abbott (Ex-President of
AAO/PAAO) et al.
Honorary Editors-in-Chief: Prof. Li-Xin Xie(Academician of Chinese Academy of
Engineering/Honorary President of Chinese Ophthalmological Society); Prof. Dennis Lam (President of APAO) and
Prof. Xiao-Xin Li (Ex-President of Chinese Ophthalmological Society).
Chief Editor: Prof. Xiu-Wen Hu (President of IJO Press).
Editors-in-Chief: Prof. Yan-Nian Hui (Ex-Director, Eye Institute of Chinese PLA) and
Prof. George Chiou (Founding chief editor of Journal of Ocular Pharmacology & Therapeutics).
Associate Editors-in-Chief include:
Prof. Ning-Li Wang (President Elect of APAO);
Prof. Ke Yao (President of Chinese Ophthalmological Society) ;
Prof.William Smiddy (Bascom Palmer Eye instituteUSA) ;
Prof.Joel Schuman (President of Association of University Professors of Ophthalmology,USA);
Prof.Yizhi Liu (Vice President of Chinese Ophtlalmology Society);
Prof.Yu-Sheng Wang (Director of Eye Institute of Chinese PLA);
Prof.Ling-Yun Cheng (Director of Ocular Pharmacology, Shiley Eye Center, USA).
IJO accepts contributions in English from all over the world. It includes mainly original articles and review articles,
both basic and clinical papers.
Instruction is Welcome Contribution is Welcome Citation is Welcome
Cooperation organization
International Council of Ophthalmology(ICO), PubMed, PMC, American Academy of Ophthalmology, Asia-Pacific, Thomson Reuters, The Charlesworth Group, Crossref,Scopus,Publons, DOAJ etc.